Literature DB >> 26402921

Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.

C Zhan1, L Yan2, L Wang1, W Jiang1, Y Zhang1, J Xi1, Y Jin1, L Chen1, Y Shi1, Z Lin1, Q Wang1.   

Abstract

In this study, we explored the gene and microRNA (miRNA) expressions profile of esophageal carcinoma. The expression data for messenger RNAs and miRNAs in normal and cancerous esophageal tissues were obtained from the Cancer Genome Atlas database and then the differentially expressed genes and miRNAs were identified. As a result, we identified 2962 genes and 45 miRNAs differentially expressed in esophageal carcinoma compared with normal esophageal tissues. Subsequently, the altered gene functions and signaling pathways were investigated using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, and these differentially expressed genes were significantly enriched in the cell cycle, cell migration, mitogen-activated protein kinase (MAPK) and toll-like receptor signaling pathway, and so on. Then the regulatory relationships between the differentially expressed miRNAs and genes were examined with Targetscan and Miranda, and the potential target sites of transcription factors (TFs) in the promoter regions of these miRNAs and genes were identified using the TRANSFAC database. Finally the TF-miRNA-gene network in esophageal cancer was established, summarizing the regulatory links among the TFs, differentially expressed miRNAs and differentially expressed genes. Factors such as core promoter-binding protein (CPBP), nuclear factor of activated T-cells 1 (NFAT-1), miR-30c-5p, were located in the central hub of this network, highlighting their vital roles in esophageal tumorigenesis. These findings may extend our understanding of the molecular mechanisms underlying esophageal carcinoma and promote new perspectives for prevention, diagnosis and treatment.
© 2015 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  GO analysis; KEGG analysis; TCGA; TF-miRNA-gene network; esophageal carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26402921     DOI: 10.1111/dote.12416

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  MicroRNA expression profiling in the colorectal normal-adenoma-carcinoma transition.

Authors:  Jian Li; Yunshi Zhong; Shilun Cai; Pinghong Zhou; Liqing Yao
Journal:  Oncol Lett       Date:  2019-06-10       Impact factor: 2.967

2.  Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma.

Authors:  Aneta Polewko-Klim; Sibo Zhu; Weicheng Wu; Yijing Xie; Ning Cai; Kexun Zhang; Zhen Zhu; Tao Qing; Ziyu Yuan; Kelin Xu; Tiejun Zhang; Ming Lu; Weimin Ye; Xingdong Chen; Chen Suo; Witold R Rudnicki
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

3.  SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016).

Authors:  M Martin-Richard; R Díaz Beveridge; V Arrazubi; M Alsina; M Galan Guzmán; A B Custodio; C Gómez; F L Muñoz; R Pazo; F Rivera
Journal:  Clin Transl Oncol       Date:  2016-11-29       Impact factor: 3.405

4.  Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.

Authors:  Jiang-Hui Zeng; Dan-Dan Xiong; Yu-Yan Pang; Yu Zhang; Rui-Xue Tang; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-05-30

5.  Label‑free quantitative proteomics and bioinformatics analyses of alcoholic liver disease in a chronic and binge mouse model.

Authors:  Yu Zhang; Cheng Zhan; Genwen Chen; Jianyong Sun
Journal:  Mol Med Rep       Date:  2018-06-26       Impact factor: 2.952

6.  Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature.

Authors:  Yu Mao; Lixin Dong; Yue Zheng; Jing Dong; Xin Li
Journal:  Front Genet       Date:  2019-04-03       Impact factor: 4.599

7.  Relationship between cervical esophageal squamous cell carcinoma and human papilloma virus infection and gene mutations.

Authors:  Masaru Fukahori; Ken Kato; Hirokazu Taniguchi; Rie Ohtomo; Naoki Takahashi; Hirokazu Shoji; Satoru Iwasa; Yoshitaka Honma; Atsuo Takashima; Tetsuya Hamaguchi; Yasuhide Yamada; Yasuhiro Shimada; Yoshinori Ito; Jun Itami; Nobukazu Hokamura; Hiroyasu Igaki; Yuji Tachimori; Keisuke Miwa; Takuji Torimura; Narikazu Boku
Journal:  Mol Clin Oncol       Date:  2020-12-30

8.  The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma.

Authors:  Tomoyuki Okumura; Hirohumi Kojima; Takeshi Miwa; Shinichi Sekine; Isaya Hashimoto; Shozo Hojo; Takuya Nagata; Yutaka Shimada
Journal:  World J Surg Oncol       Date:  2016-08-26       Impact factor: 2.754

9.  Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.

Authors:  Fenghao Sun; Xiaodong Yang; Yulin Jin; Li Chen; Lin Wang; Mengkun Shi; Cheng Zhan; Yu Shi; Qun Wang
Journal:  Mol Med Rep       Date:  2017-05-25       Impact factor: 2.952

10.  A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma.

Authors:  Yu Mao; Zhanzhao Fu; Yunjie Zhang; Lixin Dong; Yanqiu Zhang; Qiang Zhang; Xin Li; Jia Liu
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.